Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 04, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 15,812 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on October 03, 2005, and the Company was advised of it on October 04, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It is a compliance filing under Disclosure Rule 3.1.4R(1)(b) regarding the GSK Trust, a discretionary trust where all employees or former employees are potential beneficiaries. Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Key Facts for Investor Verification
- Transaction Type: Transfer of 15,812 Ordinary Shares from the GSK Trust to employee plan participants.
- Transaction Date: October 03, 2005.
- Notification Date: October 04, 2005.
- Directors Involved: Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop are noted as having interests in the trust shares.
- Financial Data: No financial metrics are included in this specific filing.